Read more

September 27, 2020
1 min read
Save

Roswell Park names senior VP of clinical investigation

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Igor Puzanov, MD, MSCI, FACP, has been promoted to senior vice president of clinical investigation at Roswell Park Comprehensive Cancer Center.

Puzanov will be responsible for planning and developing Roswell Park’s clinical research program. More than 400 clinical trials are underway at the institution.

Puzanov, who joined Roswell Park in 2016, is recognized for his expertise in early-phase cancer research.

He will continue to serve as chief of melanoma. He also will serve as medical director of Roswell Park’s Clinical Research Center.

Igor Puzanov

“Igor offers people hope. Early-phase trials have such an important role in cancer care, and often give patients and their families an option when other treatments have failed,” Candace S. Johnson, PhD, Roswell Park’s president and CEO, said in a press release. “We are so lucky to have his leadership in this crucial element of cancer care research.”